The shedding of syndecan-4 and syndecan-1 from HeLa cells and human primary macrophages is accelerated by SDF-1/CXCL12 and mediated by the matrix metalloproteinase-9 - PubMed (original) (raw)
. 2006 Jun;16(6):488-501.
doi: 10.1093/glycob/cwj098. Epub 2006 Mar 2.
Affiliations
- PMID: 16513763
- DOI: 10.1093/glycob/cwj098
The shedding of syndecan-4 and syndecan-1 from HeLa cells and human primary macrophages is accelerated by SDF-1/CXCL12 and mediated by the matrix metalloproteinase-9
Severine Brule et al. Glycobiology. 2006 Jun.
Abstract
We recently demonstrated that stromal cell-derived factor-1 (SDF-1/CXCL12) forms complexes with CXCR4, but also with syndecan-4 expressed by human primary lymphocytes and macrophages, and HeLa cells. We also suggested that syndecan-4 behaves as a SDF-1-signaling molecule. Here, we demonstrate that SDF-1 strongly accelerates the shedding of syndecan-4 ectodomains and to a lesser extent that of syndecan-1 from HeLa cells. The fact that this acceleration was not inhibited by the CXCR4 antagonist AMD3100, anti-CXCR4 mAb 12G5, and CXCR4 gene silencing suggests its CXCR4-independence. Pre-treating the cells with heparitinases I, III, or with the protein kinase C (PKC) inhibitor, bisindolylmaleimide, significantly inhibited this accelerated shedding, which suggests the involvement of both cell-surface heparan sulfate and PKC transduction pathway. In contrast, Map Kinase or NF-kappaB pathway inhibitors had no effect. Moreover, SDF-1 increases the matrix metalloproteinase-9 (MMP-9) mRNA level as well as MMP-9 activity in HeLa cells, and MMP-9 silencing by RNA interference strongly decreases the syndecan-1 and -4 ectodomain shedding accelerated by SDF-1. Finally, SDF-1 also accelerates in a CXCR4-independent manner, the shedding of syndecan-1 and -4 from human primary macrophages, which is significantly inhibited by anti-MMP-9 antibodies. This strongly indicates the role of MMP-9 in these events occurring in both a tumoral cell line and in human primary macrophages. Because MMP-9 plays a crucial role in extracellular matrix degradation during cancer cell metastasis and invasion, and shed ectodomains of syndecans may likely be involved in tumor cell proliferation, these data further indicate the multiplicity of the roles played by SDF-1 on tumor cell biology.
Similar articles
- A syndecan-4/CXCR4 complex expressed on human primary lymphocytes and macrophages and HeLa cell line binds the CXC chemokine stromal cell-derived factor-1 (SDF-1).
Hamon M, Mbemba E, Charnaux N, Slimani H, Brule S, Saffar L, Vassy R, Prost C, Lievre N, Starzec A, Gattegno L. Hamon M, et al. Glycobiology. 2004 Apr;14(4):311-23. doi: 10.1093/glycob/cwh038. Epub 2004 Mar 19. Glycobiology. 2004. PMID: 15033938 - Syndecan-4 is a signaling molecule for stromal cell-derived factor-1 (SDF-1)/ CXCL12.
Charnaux N, Brule S, Hamon M, Chaigneau T, Saffar L, Prost C, Lievre N, Gattegno L. Charnaux N, et al. FEBS J. 2005 Apr;272(8):1937-51. doi: 10.1111/j.1742-4658.2005.04624.x. FEBS J. 2005. PMID: 15819887 - RANTES (CCL5) induces a CCR5-dependent accelerated shedding of syndecan-1 (CD138) and syndecan-4 from HeLa cells and forms complexes with the shed ectodomains of these proteoglycans as well as with those of CD44.
Charnaux N, Brule S, Chaigneau T, Saffar L, Sutton A, Hamon M, Prost C, Lievre N, Vita C, Gattegno L. Charnaux N, et al. Glycobiology. 2005 Feb;15(2):119-30. doi: 10.1093/glycob/cwh148. Epub 2004 Sep 8. Glycobiology. 2005. PMID: 15355933 - Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis.
Kucia M, Reca R, Miekus K, Wanzeck J, Wojakowski W, Janowska-Wieczorek A, Ratajczak J, Ratajczak MZ. Kucia M, et al. Stem Cells. 2005 Aug;23(7):879-94. doi: 10.1634/stemcells.2004-0342. Epub 2005 May 11. Stem Cells. 2005. PMID: 15888687 Review. - Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer.
Dewan MZ, Ahmed S, Iwasaki Y, Ohba K, Toi M, Yamamoto N. Dewan MZ, et al. Biomed Pharmacother. 2006 Jul;60(6):273-6. doi: 10.1016/j.biopha.2006.06.004. Epub 2006 Jun 28. Biomed Pharmacother. 2006. PMID: 16828253 Review.
Cited by
- Soluble Syndecan-1 Levels Are Elevated in Patients with Inflammatory Bowel Disease.
Yablecovitch D, Stein A, Shabat-Simon M, Naftali T, Gabay G, Laish I, Oren A, Konikoff FM. Yablecovitch D, et al. Dig Dis Sci. 2015 Aug;60(8):2419-26. doi: 10.1007/s10620-015-3589-9. Epub 2015 Feb 22. Dig Dis Sci. 2015. PMID: 25702042 - Matrix metalloproteinase 9 plays a key role in lyme arthritis but not in dissemination of Borrelia burgdorferi.
Heilpern AJ, Wertheim W, He J, Perides G, Bronson RT, Hu LT. Heilpern AJ, et al. Infect Immun. 2009 Jul;77(7):2643-9. doi: 10.1128/IAI.00214-09. Epub 2009 Apr 13. Infect Immun. 2009. PMID: 19364840 Free PMC article. - Soluble syndecans: biomarkers for diseases and therapeutic options.
Bertrand J, Bollmann M. Bertrand J, et al. Br J Pharmacol. 2019 Jan;176(1):67-81. doi: 10.1111/bph.14397. Epub 2018 Jul 23. Br J Pharmacol. 2019. PMID: 29931674 Free PMC article. Review. - Syndecan-1 Shedding Inhibition to Protect Against Ischemic Acute Kidney Injury Through HGF Target Signaling Pathway.
Lu Z, Song N, Shen B, Xu X, Fang Y, Shi Y, Ning Y, Hu J, Dai Y, Ding X, Zou J, Teng J. Lu Z, et al. Transplantation. 2018 Jul;102(7):e331-e344. doi: 10.1097/TP.0000000000002170. Transplantation. 2018. PMID: 29557914 Free PMC article. - Syndecan-1 is an in vivo suppressor of Gram-positive toxic shock.
Hayashida K, Chen Y, Bartlett AH, Park PW. Hayashida K, et al. J Biol Chem. 2008 Jul 18;283(29):19895-903. doi: 10.1074/jbc.M801614200. Epub 2008 May 22. J Biol Chem. 2008. PMID: 18499671 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous